These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6811280)

  • 21. Formation of the thiol adducts of 4'-(9-acridinylamino)methanesulfon-m-anisidide and their binding to deoxyribonucleic acid.
    Wong A; Huang CH; Hwang SM; Prestayko AW; Crooke ST
    Biochem Pharmacol; 1986 May; 35(10):1655-62. PubMed ID: 3754750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Zwelling LA; Kerrigan D; Michaels S
    Cancer Res; 1982 Jul; 42(7):2687-91. PubMed ID: 6896293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumour activity of substituted 9-anilinoacridines--comparison of in vivo and in vitro testing systems.
    Baguley BC; Nash R
    Eur J Cancer (1965); 1981 Jun; 17(6):671-9. PubMed ID: 6895501
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
    Nelson EM; Tewey KM; Liu LF
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1361-5. PubMed ID: 6324188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative and qualitative effects of m-AMSA (amsacrine) on cellular immune components.
    Miller T; Bleumink N
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1307-16. PubMed ID: 6386483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs.
    Finlay GJ; Wilson WR; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1695-701. PubMed ID: 2561099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the fluorescence labeling of human red blood cell membrane ghosts with 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Wong A; Crooke ST
    Biochem Pharmacol; 1985 Sep; 34(18):3265-73. PubMed ID: 3840021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA-synthesis and tumor growth inhibitions by AGGA, a bleomycin-amsacrine hybrid derivative.
    Bailly C; Pommery N; Henichart JP
    Cancer Lett; 1988 Jan; 38(3):321-8. PubMed ID: 2450638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the topoisomerase II-mediated DNA scission produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide in L1210 murine leukemia cells.
    Zwelling LA; Kerrigan D; Marton LJ
    Cancer Res; 1985 Mar; 45(3):1122-6. PubMed ID: 2982483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative sequestration of m-AMSA in L1210 cells.
    Zwelling LA; Kerrigan D; Michaels S; Kohn KW
    Biochem Pharmacol; 1982 Oct; 31(20):3269-77. PubMed ID: 6897359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amsacrine-induced lesions in DNA and their modulation by novobiocin and 2,4-dinitrophenol.
    Shibuya ML; Buddenbaum WE; Don AL; Utsumi H; Suciu D; Kosaka T; Elkind MM
    Cancer Res; 1991 Jan; 51(2):573-80. PubMed ID: 1985775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-cycle-stage specificity of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and interaction with ionizing radiation in mammalian cell cultures.
    Wilson WR; Whitmore GF
    Radiat Res; 1981 Jul; 87(1):121-36. PubMed ID: 7019954
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of DNA-protein crosslinks by antitumor 1-nitro-9-aminoacridines in L1210 leukemia cells.
    Woynarowski JM; McNamee H; Szmigiero L; Beerman TA; Konopa J
    Biochem Pharmacol; 1989 Nov; 38(22):4095-101. PubMed ID: 2557039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents.
    Pommier Y; Schwartz RE; Kohn KW; Zwelling LA
    Biochemistry; 1984 Jul; 23(14):3194-201. PubMed ID: 6087890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of swiveling at sites of intercalator-induced protein-associated deoxyribonucleic acid strand breaks in mammalian cell nucleoids.
    Pommier Y; Mattern MR; Schwartz RE; Zwelling LA
    Biochemistry; 1984 Jun; 23(13):2922-7. PubMed ID: 6547848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of adriamycin and mAMSA. II. Studies with V79 and human tumour multicellular spheroids.
    West CM; Stratford IJ
    Cancer Chemother Pharmacol; 1987; 20(2):109-14. PubMed ID: 2822273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II clinical trial of 4'-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in the treatment of advanced non-Hodgkin's lymphomas.
    Abate G; Villari P; Comella P; D'Aprile M; Castello G; Silvestro P; Zarrilli D; Pergola M
    Haematologica; 1985; 70(1):35-8. PubMed ID: 3924754
    [No Abstract]   [Full Text] [Related]  

  • 38. m-AMSA: a new anticancer agent.
    Rozencweig M; Von Hoff DD; Legha SS; Cysyk RL; Muggia FM
    Recent Results Cancer Res; 1980; 74():250-7. PubMed ID: 6893753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlorpromazine: a potential anticancer agent?
    Darkin S; McQuillan J; Ralph RK
    Biochem Biophys Res Commun; 1984 Nov; 125(1):184-91. PubMed ID: 6439202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
    Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA
    Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.